B7RP Antibodies

Santa Cruz Biotechnology features a diverse variety of B7RP monoclonal antibodies for advanced research in immunology and cell biology. B7RP monoclonal antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). B7RP, also known as B7-H4, plays a critical role in regulating immune responses by modulating T cell activation and promoting immune tolerance. B7RP expression is often associated with various pathological conditions, including cancer and autoimmune diseases, making it a significant target for therapeutic interventions. Understanding B7RP function is essential for developing strategies to enhance immune responses or inhibit unwanted immune activity. Researchers worldwide rely on B7RP monoclonal antibodies to investigate immune system regulation and its impact on various diseases. Current studies focusing on B7RP continue to reveal new insights into immune system modulation and potential therapeutic applications. B7RP monoclonal antibodies from Santa Cruz Biotechnology enable researchers to advance scientific understanding of immune regulation and its implications in human health.